io9 discoveries are protected.

Cancer Prognostic Biomarkers

License executed with UCSD for provisional patent application: Cancer Prognostic Biomarkers. The invention describes utilizing hotspot mutations in cancers for predicting patient survival and personalizing treatment.

AI Architecture For Predicting Cancer Biomarkers

License amendment executed with UCSD to include provisional patent application: Artificial Intelligence Architecture For Predicting Cancer Biomarkers. The invention describes direct detection of clinical biomarkers from commonly generated tissue slides.

Mapping Mutation Hotspots

The invention describes utilizing hotspot mutations in cancers for predicting patient survival and personalizing treatment. License executed with UCSD for provisional patent application: Cancer Prognostic Biomarkers. T

A method for treatment of HPV– HNSC patients with loss of petite arm of chromosome 9 loss.

License in process with UCSD for a provisional patent application: Drugs effective in HNSC cell lines with 9p loss. The invention describes a method for treatment of HPV HNSC patients with loss of petite arm of chromosome 9 loss.

Clinically actionable genetic biomarker for the treatment of solid tumors

License in process with UCSD for a provisional patent application: Detecting homologous recombination deficiency in cancer. The invention describes the detection of a clinically actionable genetic biomarker for the treatment of solid tumors.